Table 1 Patient and tumor characteristics relative to chemotherapy
| Â | Anthracycline/taxane-based | Platinum/taxane-based |
|---|---|---|
n (%) or mean (SD) | n (%) or mean (SD) | |
Overall | 55 | 66 |
Age at first diagnosis | 48.3 (9.6) | 50.3 (12.1) |
Age | ||
 < 45 y | 19 (34.5) | 21 (31.8) |
 45–54 y | 21 (38.2) | 19 (28.8) |
 > 54 y | 15 (27.3) | 26 (39.4) |
Tumor size | ||
 ≤ 2 cm | 20 (36.4) | 27 (40.9) |
 > 2 cm | 35 (63.6) | 39 (59.1) |
Grading | ||
 1 or 2 | 10 (18.2) | 10 (15.2) |
 3 | 45 (81.8) | 56 (84.8) |
Ki-67 | ||
 < 36% | 13 (23.6) | 14 (21.2) |
 ≥ 36% | 42 (76.4) | 52 (78.8) |
pCR | ||
 No | 32 (58.2) | 33 (50.0) |
 Yes | 23 (41.8) | 33 (50.0) |